{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:27Z","timestamp":1787027367293,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019257","name":"Key Laboratory of Myocardial Ischemia, Ministry of Education","doi-asserted-by":"publisher","award":["KF202408"],"award-info":[{"award-number":["KF202408"]}],"id":[{"id":"10.13039\/501100019257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82061130223"],"award-info":[{"award-number":["82061130223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62135002"],"award-info":[{"award-number":["62135002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Heilongjiang Province","award":["2022ZX06C07"],"award-info":[{"award-number":["2022ZX06C07"]}]},{"name":"Key Research and Development Program of Heilongjiang Province","award":["2022ZX01A28"],"award-info":[{"award-number":["2022ZX01A28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06072-5","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:14:58Z","timestamp":1781248498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of residual cholesterol and inflammation risk on non-culprit plaque progression in patients with acute coronary syndrome: a serial optical coherence tomography study"],"prefix":"10.1186","volume":"26","author":[{"given":"Dirui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boling","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sining","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"6072_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41569-023-00884-0","volume":"20","author":"A Timmis","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023;20:778\u201388. https:\/\/doi.org\/10.1038\/s41569-023-00884-0.","journal-title":"Nat Rev Cardiol"},{"key":"6072_CR2","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","journal-title":"Eur Heart J"},{"key":"6072_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","volume":"397","author":"D Erlinge","year":"2021","unstructured":"Erlinge D, Maehara A, Ben-Yehuda O, B\u00f8tker HE, Maeng M, Kj\u00f8ller-Hansen L, et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021;397:985\u201395. https:\/\/doi.org\/10.1016\/S0140-6736(21)00249-X.","journal-title":"Lancet"},{"key":"6072_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","volume":"364","author":"GW Stone","year":"2011","unstructured":"Stone GW, Maehara A, Lansky AJ, De Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1002358.","journal-title":"N Engl J Med"},{"key":"6072_CR5","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","volume":"46","author":"B Bay","year":"2025","unstructured":"Bay B, Tanner R, Gao M, Oliva A, Sartori S, Vogel B, et al. Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention. Eur Heart J. 2025;46:3167\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf196.","journal-title":"Eur Heart J"},{"key":"6072_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2020.11.033","volume":"317","author":"Y Gao","year":"2021","unstructured":"Gao Y, Lou Y, Liu Y, Wu S, Xi Z, Wang X, et al. The relationship between residual cholesterol risk and plaque characteristics in patients with acute coronary syndrome: insights from an optical coherence tomography study. Atherosclerosis. 2021;317:10\u20135. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.11.033.","journal-title":"Atherosclerosis"},{"key":"6072_CR7","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2023.01.030","volume":"81","author":"S Jiang","year":"2023","unstructured":"Jiang S, Fang C, Xu X, Xing L, Sun S, Peng C, et al. Identification of High-Risk Coronary Lesions by 3-Vessel Optical Coherence Tomography. J Am Coll Cardiol. 2023;81:1217\u201330. https:\/\/doi.org\/10.1016\/j.jacc.2023.01.030.","journal-title":"J Am Coll Cardiol"},{"key":"6072_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","volume":"41","author":"F Prati","year":"2020","unstructured":"Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41:383\u201391. https:\/\/doi.org\/10.1093\/eurheartj\/ehz520.","journal-title":"Eur Heart J"},{"key":"6072_CR9","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1093\/eurheartj\/ehab433","volume":"42","author":"E Kedhi","year":"2021","unstructured":"Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT\u2013FFR trial. Eur Heart J. 2021;42:4671\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab433.","journal-title":"Eur Heart J"},{"key":"6072_CR10","doi-asserted-by":"publisher","first-page":"e006347","DOI":"10.1161\/CIRCIMAGING.117.006347","volume":"10","author":"MH Yamamoto","year":"2017","unstructured":"Yamamoto MH, Yamashita K, Matsumura M, Fujino A, Ishida M, Ebara S, et al. Serial 3-vessel optical coherence tomography and intravascular ultrasound analysis of changing morphologies associated with lesion progression in patients with stable angina pectoris. Circ Cardiovasc Imaging. 2017;10:e006347. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.006347.","journal-title":"Circ Cardiovasc Imaging"},{"key":"6072_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034458","author":"K Yamaji","year":"2024","unstructured":"Yamaji K, Kanenawa K, Morofuji T, Nishikawa R, Imada K, Kohjitani H, et al. Serial optical coherence tomography assessment of coronary atherosclerosis and long-term clinical outcomes. J Am Heart Assoc. 2024. https:\/\/doi.org\/10.1161\/JAHA.123.034458.","journal-title":"J Am Heart Assoc"},{"key":"6072_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401:1293\u2013301. https:\/\/doi.org\/10.1016\/S0140-6736(23)00215-5.","journal-title":"Lancet"},{"key":"6072_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-023-01826-3","volume":"22","author":"L Yang","year":"2023","unstructured":"Yang L, Yue Q, Fang F, Zhang Y, Liu P, Zhang Z, et al. Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease. Cardiovasc Diabetol. 2023;22:96\u2013106. https:\/\/doi.org\/10.1186\/s12933-023-01826-3.","journal-title":"Cardiovasc Diabetol"},{"key":"6072_CR14","doi-asserted-by":"publisher","first-page":"119092","DOI":"10.1016\/j.atherosclerosis.2024.119092","volume":"401","author":"B Yi","year":"2025","unstructured":"Yi B, He L, Zhang D, Zeng M, Zhao C, Meng W, et al. Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes. Atherosclerosis. 2025;401:119092. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119092.","journal-title":"Atherosclerosis"},{"key":"6072_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies. J Am Coll Cardiol. 2012;59:1058\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.079.","journal-title":"J Am Coll Cardiol"},{"key":"6072_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.08.014","volume":"14","author":"M Araki","year":"2021","unstructured":"Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, et al. Predictors of rapid plaque progression. JACC Cardiovasc Imaging. 2021;14:1628\u201338. https:\/\/doi.org\/10.1016\/j.jcmg.2020.08.014.","journal-title":"JACC Cardiovasc Imaging"},{"key":"6072_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1536\/ihj.54.64","volume":"54","author":"M Orii","year":"2013","unstructured":"Orii M, Kubo T, Tanaka A, Kitabata H, Ino Y, Shiono Y, et al. Inter-scan reproducibility of geometric coronary artery measurements using frequency-domain optical coherence tomography. Int Heart J. 2013;54:64\u20137. https:\/\/doi.org\/10.1536\/ihj.54.64.","journal-title":"Int Heart J"},{"key":"6072_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/ehjci\/jev229","volume":"17","author":"E Gerbaud","year":"2016","unstructured":"Gerbaud E, Weisz G, Tanaka A, Kashiwagi M, Shimizu T, Wang L, et al. Multi-laboratory inter-institute reproducibility study of IVOCT and IVUS assessments using published consensus document definitions. Eur Heart J \u2013 Cardiovasc Imaging. 2016;17:756\u201364. https:\/\/doi.org\/10.1093\/ehjci\/jev229.","journal-title":"Eur Heart J \u2013 Cardiovasc Imaging"},{"key":"6072_CR19","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","volume":"132","author":"EA Bohula","year":"2015","unstructured":"Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, et al. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation. 2015;132:1224\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018381.","journal-title":"Circulation"},{"key":"6072_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20\u20138. https:\/\/doi.org\/10.1056\/NEJMoa042378.","journal-title":"N Engl J Med"},{"key":"6072_CR21","doi-asserted-by":"publisher","first-page":"e003470","DOI":"10.1161\/CIRCOUTCOMES.116.003470","volume":"10","author":"Y Lu","year":"2017","unstructured":"Lu Y, Zhou S, Dreyer RP, Spatz ES, Geda M, Lorenze NP, et al. Sex differences in inflammatory markers and health status among young adults with acute myocardial infarction: results from the VIRGO (variation in recovery: role of gender on outcomes of young acute myocardial infarction patients) study. Circ Cardiovasc Qual Outcomes. 2017;10:e003470. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.003470.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"6072_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jcin.2022.01.298","volume":"15","author":"H Jia","year":"2022","unstructured":"Jia H, Dai J, He L, Xu Y, Shi Y, Zhao L, et al. EROSION III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency. JACC Cardiovasc Interv. 2022;15:846\u201356. https:\/\/doi.org\/10.1016\/j.jcin.2022.01.298.","journal-title":"JACC Cardiovasc Interv"},{"key":"6072_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4244\/EIJ-D-20-00299","volume":"17","author":"L He","year":"2021","unstructured":"He L, Qin Y, Xu Y, Hu S, Wang Y, Zeng M, et al. Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study. Eurointervention. 2021;17:497\u2013505. https:\/\/doi.org\/10.4244\/EIJ-D-20-00299.","journal-title":"Eurointervention"},{"key":"6072_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/CIRCRESAHA.115.306471","volume":"118","author":"MD Shapiro","year":"2016","unstructured":"Shapiro MD, Fazio S. From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res. 2016;118:732\u201349. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306471.","journal-title":"Circ Res"},{"key":"6072_CR25","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","volume":"37","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016;37:1720\u20132. https:\/\/doi.org\/10.1093\/eurheartj\/ehw024.","journal-title":"Eur Heart J"},{"key":"6072_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis. J Am Coll Cardiol. 2009;54:2129\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2009.09.009.","journal-title":"J Am Coll Cardiol"},{"key":"6072_CR27","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868\u201374. https:\/\/doi.org\/10.1038\/nature01323.","journal-title":"Nature"},{"key":"6072_CR28","doi-asserted-by":"publisher","first-page":"132924","DOI":"10.1016\/j.ijcard.2024.132924","volume":"421","author":"M Katamine","year":"2025","unstructured":"Katamine M, Minami Y, Nagata T, Asakura K, Muramatsu Y, Kinoshita D, et al. High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study. Int J Cardiol. 2025;421:132924. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132924.","journal-title":"Int J Cardiol"},{"key":"6072_CR29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s12265-022-10250-z","volume":"15","author":"S Budassi","year":"2022","unstructured":"Budassi S, Biccir\u00e8 FG, Paoletti G, Marco V, Boi A, Romagnoli E, et al. The role of the association between serum C-reactive protein levels and coronary plaque macrophage accumulation in predicting clinical events - results from the CLIMA registry. J Cardiovasc Transl Res. 2022;15:1377\u201384. https:\/\/doi.org\/10.1007\/s12265-022-10250-z.","journal-title":"J Cardiovasc Transl Res"},{"key":"6072_CR30","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa0807646.","journal-title":"N Engl J Med"},{"key":"6072_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/CIRCULATIONAHA.124.071855","volume":"151","author":"J Dai","year":"2025","unstructured":"Dai J, Zhao J, Xu X, Chen Y, Sun S, Li S, et al. Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology? Circulation. 2025;151:1098\u2013110. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071855.","journal-title":"Circulation"},{"key":"6072_CR32","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"key":"6072_CR33","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif J-C, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"key":"6072_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"key":"6072_CR35","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","volume":"41","author":"PM Ridker","year":"2020","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Libby P. Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis. Eur Heart J. 2020;41:2153\u201363. https:\/\/doi.org\/10.1093\/eurheartj\/ehz542.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06072-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:07:15Z","timestamp":1787026035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6072"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06072-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the 2nd Affiliated Hospital of Harbin Medical University (Harbin, China) and adhered to the principles of the Declaration of Helsinki (Approval No. YJSKY2024-333), with all participants providing written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"719"}}